Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

332 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan.
Kogure T, Ueno Y, Fukushima K, Nagasaki F, Kondo Y, Inoue J, Matsuda Y, Kakazu E, Yamamoto T, Onodera H, Miyazaki Y, Okamoto H, Akahane T, Kobayashi T, Mano Y, Iwasaki T, Ishii M, Shimosegawa T. Kogure T, et al. Among authors: akahane t. World J Gastroenterol. 2008 Dec 21;14(47):7225-4230. doi: 10.3748/wjg.14.7225. World J Gastroenterol. 2008. PMID: 19084938 Free PMC article. Clinical Trial.
Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan.
Inoue J, Ueno Y, Nagasaki F, Akahane T, Fukushima K, Kogure T, Kondo Y, Kakazu E, Tamai K, Kido O, Nakagome Y, Ninomiya M, Obara N, Wakui Y, Takahashi M, Okamoto H, Shimosegawa T. Inoue J, et al. Among authors: akahane t. J Gastroenterol. 2009;44(4):329-37. doi: 10.1007/s00535-009-0012-3. Epub 2009 Mar 7. J Gastroenterol. 2009. PMID: 19271116
1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial.
Kondo Y, Kato T, Kimura O, Iwata T, Ninomiya M, Kakazu E, Miura M, Akahane T, Miyazaki Y, Kobayashi T, Ishii M, Kisara N, Sasaki K, Nakayama H, Igarashi T, Obara N, Ueno Y, Morosawa T, Shimosegawa T. Kondo Y, et al. Among authors: akahane t. PLoS One. 2013 May 23;8(5):e63672. doi: 10.1371/journal.pone.0063672. Print 2013. PLoS One. 2013. PMID: 23717463 Free PMC article. Clinical Trial.
Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Tsuji K, Kurosaki M, Itakura J, Mori N, Takaki S, Hasebe C, Akahane T, Joko K, Yagisawa H, Takezawa J, Nakata R, Kusakabe A, Kojima Y, Kimura H, Tamada T, Kobashi H, Mitsuda A, Kondou M, Ogawa C, Uchida Y, Sohda T, Narita R, Izumi N. Tsuji K, et al. Among authors: akahane t. J Gastroenterol. 2018 Oct;53(10):1142-1150. doi: 10.1007/s00535-018-1455-1. Epub 2018 Apr 6. J Gastroenterol. 2018. PMID: 29626296
Comparison of hepatitis B virus genotypes B and C among chronically hepatitis B virus-infected patients who received nucleos(t)ide analogs: A multicenter retrospective study.
Inoue J, Akahane T, Nakayama H, Kimura O, Kobayashi T, Kisara N, Sato T, Morosawa T, Izuma M, Kakazu E, Ninomiya M, Iwata T, Takai S, Nakamura T, Sano A, Niitsuma H, Masamune A; THERME Study Group. Inoue J, et al. Among authors: akahane t. Hepatol Res. 2019 Nov;49(11):1263-1274. doi: 10.1111/hepr.13398. Epub 2019 Jul 16. Hepatol Res. 2019. PMID: 31254482
Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C.
Itakura J, Kurosaki M, Kakizaki S, Amano K, Nakayama N, Inoue J, Endo T, Marusawa H, Hasebe C, Joko K, Wada S, Akahane T, Koushima Y, Ogawa C, Kanto T, Mizokami M, Izumi N. Itakura J, et al. Among authors: akahane t. JHEP Rep. 2020 Jun 18;2(5):100138. doi: 10.1016/j.jhepr.2020.100138. eCollection 2020 Oct. JHEP Rep. 2020. PMID: 32817930 Free PMC article.
Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study.
Inoue J, Kobayashi T, Akahane T, Kimura O, Sato K, Ninomiya M, Iwata T, Takai S, Kisara N, Sato T, Nagasaki F, Miura M, Nakamura T, Umetsu T, Sano A, Tsuruoka M, Onuki M, Niitsuma H, Masamune A, Therme Study Group. Inoue J, et al. Among authors: akahane t. J Clin Med. 2022 Apr 22;11(9):2354. doi: 10.3390/jcm11092354. J Clin Med. 2022. PMID: 35566481 Free PMC article.
Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study.
Sato K, Inoue J, Akahane T, Kobayashi T, Sato S, Kisara N, Ninomiya M, Iwata T, Sano A, Tsuruoka M, Onuki M, Masamune A. Sato K, et al. Among authors: akahane t. Medicine (Baltimore). 2022 Sep 30;101(39):e30630. doi: 10.1097/MD.0000000000030630. Medicine (Baltimore). 2022. PMID: 36181074 Free PMC article. Clinical Trial.
332 results